Big Gain For Cue Biopharma, Inc.
Mon, May 10, 2021 at 05:30 PM
Cue Biopharma, Inc. (CUE:NASDAQ) rocketted at $14.38, representing a gain of 27.7%. The stock appeared on our News Catalysts scanner on Mon, May 10, 2021 at 04:36 PM in the 'BIOTECH' category. From Fri, Apr 23, 2021, the stock recorded 50.00% Up Days and 36.36% Green Days
The share price of the company has been moving sideways in recent weeks.
About Cue Biopharma, Inc. (CUE:NASDAQ)
Cue Biopharma Inc is a biopharmaceutical company developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders.
Top 10 Gainers:
- RTPY (RTPY:NASDAQ), 100%
- Tecnoglass Inc. (TGLS:NASDAQ), 30.96%
- Obalon Therapeutics, Inc. (OBLN:NASDAQ), 30.45%
- Cue Biopharma, Inc. (CUE:NASDAQ), 27.71%
- Soliton, Inc. (SOLY:NASDAQ), 24.5%
- ALF (ALF:NASDAQ), 23.51%
- PolarityTE, Inc. (PTE:NASDAQ), 23.18%
- Exterran Corporation (EXTN:NYSE), 21.81%
- UCL (UCL:NASDAQ), 21.4%
- Live Ventures Incorporated (LIVE:NASDAQ), 20.03%